ABSTRACT
Interferon regulatory factor 5 (IRF5) is a master regulator of macrophage phenotype and a key transcription factor involved in expression of proinflammatory cytokine responses to microbial and viral infection. Here, we show that IRF5 controls cellular and metabolic responses. By integrating ChIP sequencing (ChIP-Seq) and assay for transposase-accessible chromatin using sequencing (ATAC)-seq data sets, we found that IRF5 directly regulates metabolic genes such as hexokinase-2 (Hk2). The interaction of IRF5 and metabolic genes had a functional consequence, as Irf5-/- airway macrophages but not bone marrow-derived macrophages (BMDMs) were characterized by a quiescent metabolic phenotype at baseline and had reduced ability to utilize oxidative phosphorylation after Toll-like receptor (TLR)-3 activation, in comparison to controls, ex vivo. In a murine model of influenza infection, IRF5 deficiency had no effect on viral load in comparison to wild-type controls but controlled metabolic responses to viral infection, as IRF5 deficiency led to reduced expression of Sirt6 and Hk2. Together, our data indicate that IRF5 is a key component of AM metabolic responses following influenza infection and TLR-3 activation.
Subject(s)
Energy Metabolism/immunology , Gene Expression Regulation/immunology , Interferon Regulatory Factors/immunology , Macrophages/immunology , Respiratory System/cytology , Animals , Cells, Cultured , Chromatin Immunoprecipitation Sequencing/methods , Energy Metabolism/genetics , Female , Hexokinase/genetics , Hexokinase/immunology , Hexokinase/metabolism , Humans , Interferon Regulatory Factors/genetics , Interferon Regulatory Factors/metabolism , Macrophages/metabolism , Mice, Inbred C57BL , Mice, Knockout , Sirtuins/genetics , Sirtuins/immunology , Sirtuins/metabolism , Toll-Like Receptor 3/genetics , Toll-Like Receptor 3/immunology , Toll-Like Receptor 3/metabolismABSTRACT
Stimulation of the NF-kappaB pathway often causes p65-p50 and p50-p50 dimers to be simultaneously present in the cell nucleus. A natural polymorphism at nucleotide -863 in the human TNF promoter (encoding tumor necrosis factor [TNF]) region provides an opportunity to dissect the functional interaction of p65-p50 and p50-p50 at a single NF-kappaB binding site. We found that this site normally binds both p65-p50 and p50-p50, but a single base change specifically inhibits p50-p50 binding. Reporter gene analysis in COS-7 cells expressing both p65-p50 and p50-p50 shows that the ability to bind p50-p50 reduces the enhancer effect of this NF-kappaB site. Using an adenoviral reporter assay, we found that the variant which binds p50-p50 results in a reduction of lipopolysaccharide-inducible gene expression in primary human monocytes. This finding adds to a growing body of experimental evidence that p50-p50 can inhibit the transactivating effects of p65-p50 and illustrates the potential for genetic modulation of inflammatory gene regulation in humans by subtle nucleotide changes that alter the relative binding affinities of different forms of the NF-kappaB complex.
Subject(s)
NF-kappa B/metabolism , Polymorphism, Genetic/genetics , Promoter Regions, Genetic/genetics , Tumor Necrosis Factor-alpha/genetics , Adenoviridae/genetics , Animals , Binding Sites , COS Cells , Cell Fractionation , Cell Line , Cells, Cultured , Cloning, Molecular , Dimerization , Gene Expression Regulation , Genes, Reporter/genetics , Humans , Lipopolysaccharides/pharmacology , Macrophages/cytology , Macrophages/metabolism , Monocytes/cytology , Monocytes/drug effects , Monocytes/metabolism , NF-kappa B/chemistry , NF-kappa B/genetics , NF-kappa B p50 Subunit , Transcriptional Activation/physiologyABSTRACT
Interferon regulatory factor 5 (IRF5) is a key transcription factor involved in the control of the expression of proinflammatory cytokine and responses to infection, but its role in regulating pulmonary immune responses to allergen is unknown. We used genetic ablation, adenoviral vector-driven overexpression, and adoptive transfer approaches to interrogate the role of IRF5 in pulmonary immunity and during challenge with the aeroallergen, house dust mite. Global IRF5 deficiency resulted in impaired lung function and extracellular matrix (ECM) deposition. IRF5 was also essential for effective responses to inhaled allergen, controlling airway hyperresponsiveness, mucus secretion, and eosinophilic inflammation. Adoptive transfer of IRF5-deficient alveolar macrophages into the wild-type pulmonary milieu was sufficient to drive airway hyperreactivity, at baseline or following antigen challenge. These data identify IRF5-expressing macrophages as a key component of the immune defense of the airways. Manipulation of IRF5 activity in the lung could therefore be a viable strategy for the redirection of pulmonary immune responses and, thus, the treatment of lung disorders.
Subject(s)
Eosinophils/immunology , Hypersensitivity/immunology , Interferon Regulatory Factors/metabolism , Lung/physiology , Macrophages, Alveolar/immunology , Adoptive Transfer , Animals , Antigens, Dermatophagoides/immunology , Cell Movement , Cells, Cultured , Extracellular Matrix/metabolism , Female , Interferon Regulatory Factors/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Mucus/metabolism , Pyroglyphidae/immunologyABSTRACT
Transcriptional activation of various genes by lipopolysaccharide (LPS) is known to be mediated, at least in part, by the NF-kappa B/Rel family of transcription factors. We have identified a novel kappa B element located immediately downstream of the TNF-alpha gene that is conserved together with its flanking sequences across species lines and can act as an LPS-responsive enhancer for reporter gene constructs driven by the minimal TNF promoter. In extracts from activated murine macrophages and macrophage cell lines this element binds several non-canonical NF-kappa B/Rel complexes, in addition to p50 (NFKB1) homodimer and p50-p65 (NKFB1-RelA) heterodimer. Combination of high-resolution electrophoretic mobility shift assays (EMSA) with monospecific antibodies and u.v.-cross-linking indicates that the prominent slow migrating complex III contain p65 homodimer and c-Rel. The appearance of complex III in EMSA parallels the translocation of p65 and c-Rel into the nucleus and occurs shortly after LPS induction. Transfection experiments with reporter constructs driven by this kappa B element indicate strong inducibility by LPS and p65, moderate inducibility by c-Rel and repression by p50. Functional activity of sandwich TNF-CAT-TNF constructs further suggests that LPS-inducible transcriptional activation of the TNF gene in murine macrophages may be partly mediated by a downstream enhancer.
Subject(s)
Enhancer Elements, Genetic , Macrophages/metabolism , NF-kappa B/metabolism , Regulatory Sequences, Nucleic Acid , Tumor Necrosis Factor-alpha/genetics , Animals , Base Sequence , Biological Evolution , Chloramphenicol O-Acetyltransferase/genetics , Conserved Sequence , DNA , Lipopolysaccharides/pharmacology , Macrophage Activation , Macrophages/drug effects , Mice , Molecular Sequence Data , Protein Binding , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-relABSTRACT
The TNF region within the MHC includes a number of immunologically important genes. Microsatellites TNFa and TNFb adjacent to TNF exhibit extensive polymorphism. Employing a PCR-based technique, we identified TNFab haplotypes and defined their distribution in 97 controls and 48 diabetics of Caucasoid origin in a search for other genes within the MHC potentially associated with IDDM. Twenty-five different TNFab haplotypes were identified. A significant difference (p < 0.0005) in frequency between patients and controls was found for TNFa1b5 (relative risk 53). However, no other TNFab microsatellites demonstrated significantly different frequencies. Among diabetics TNFa1b5 was found to be in linkage disequilibrium with HLA-DR3-B18, a haplotype known to be associated with IDDM. Thus the increased frequency of TNFa1b5 among diabetics could reflect a linkage disequilibrium with a gene within the TNF region or with other genes, including the HLAs, which characterize this haplotype. In both controls and diabetics TNFa2b3 and TNFa7b4 were in linkage disequilibrium with DR3-B8 and DR7, respectively. Among diabetics, TNFa2b1 and TNFa6b5 were in linkage disequilibrium with DR4-B62 and DR4-B44, respectively. It is intriguing that TNFab haplotypes, represented by a short piece of about 200 nucleotides in the untranslated region upstream of TNF beta gene, maintain strong linkage disequilibria with different HLA haplotypes extending over 1 million base pairs. The identification of TNFab microsatellites exhibiting a high polymorphic index in a region lacking known polymorphic markers may provide potentially important information regarding the association of HLA haplotypes with autoimmune diseases, as they are in close proximity to other genes of immunologic importance.
Subject(s)
Alleles , DNA, Satellite/analysis , Diabetes Mellitus, Type 1/genetics , Haplotypes/immunology , Linkage Disequilibrium/immunology , Polymorphism, Genetic/immunology , Tumor Necrosis Factor-alpha/genetics , Diabetes Mellitus, Type 1/immunology , HLA-DR4 Antigen/genetics , Humans , Tumor Necrosis Factor-alpha/analysisABSTRACT
Tumor necrosis factor (TNF) is recognized as a central mediator of sepsis, septic shock, and multiple organ failure. These host reactions are associated with increased TNF levels in circulation, presumably due to increased TNF production. A previously described nucleotide variation at position -308 in the promoter region of the human TNF gene was shown to be associated with the clinical outcome of malaria. In this study we addressed the relevance of the -308 polymorphism for expression of the human TNF gene in response to bacterial endo- toxin in vivo and in vitro. First, we typed 80 patients suffering from severe sepsis and 153 healthy individuals and found no association of the -308 variation with incidence of the disease. In contrast, the NcoI marker in the closely linked lymphotoxin-alpha (LT-alpha) gene showed association with survivaL This discrepancy can be explained by the linkage of the TNFB2(NcoI) allele to the common TNF1 (-308) allele. Second, we generated reporter gene constructs with the promoter deletions and with both -308 variation in the context of the extended human TNF promoter region. Although such constructs were highly inducible by lipopolysaccharide (LPS) in transient transfections into a macrophage cell line, the -308 variation had no significant effect on transcription, consistent with the promoter deletion study. We conclude that the functional consequence of the -308 polymorphism may be unrelated to transcriptional response of the TNF gene to bacterial endotoxin.
Subject(s)
Lipopolysaccharides/pharmacology , Polymorphism, Genetic , Promoter Regions, Genetic , Sepsis/genetics , Tumor Necrosis Factor-alpha/genetics , Adult , Aged , Alleles , Animals , Cell Line , Deoxyribonucleases, Type II Site-Specific , Gene Deletion , Heterozygote , Homozygote , Humans , Mice , Middle Aged , Mutagenesis, Site-Directed , Sepsis/mortality , Survival RateABSTRACT
Genome DNA encoding the N-part of human CD4 gene located in the 15 kilobase (kb) Sau3a restriction fragment was cloned and nucleotide sequence of a part (3430 b.p.) of this fragment determined. Exons 2 and 3, intron 2, and partially introns 2 and 3 of this gene were located in the sequenced fragment. Six Alu repeats and open reading frames (ORFs) coding for proteins very close to C5 and C3 components of the complement were detected in this fragment.
Subject(s)
CD4 Antigens/genetics , Exons , T-Lymphocytes/immunology , Amino Acid Sequence , Base Sequence , Complement C3/genetics , Complement C5/genetics , DNA , Humans , Molecular Sequence Data , Open Reading Frames , RNA, Messenger/genetics , Restriction Mapping , Sequence Homology, Nucleic AcidABSTRACT
IRF5 plays a key role in the induction of pro-inflammatory cytokines, contributing to the plasticity and polarisation of macrophages to an M1 phenotype and initiation of a potent T(H)1-T(H)17 response. To better understand the means of IRF5 transcriptional action, we conducted a screen for IRF5-interacting partners by affinity purification coupled to mass spectrometry and identified KAP1/TRIM28 as a novel protein-protein interaction partner of IRF5. KAP1 acts as a transcriptional co-repressor, chiefly via recruitment of complexes involved in chromatin silencing, such as histone deacetylases and methyltransferases. We mapped the N-terminus of IRF5, encompassing its DNA-binding domain together with a highly intrinsically disordered region, as crucial for the IRF5-KAP1 interaction interface, and demonstrated that IRF5 can also form complexes with the methyltransferase SETDB1. Knockdown of KAP1 (TRIM28) gene expression in human M1 macrophages potentiated IRF5-mediated expression of TNF and other M1 macrophage markers. This effect may be linked to methyltransferase activity of SETDB1, such as trimethylation of lysine 9 of histone 3 (H3K9me3), deposition of which was decreased at the human TNF locus upon KAP1 knockdown. Our study furthers an understanding of the complex molecular interactions between the TRIM and IRF protein families, and highlights a role of the inhibitory properties of KAP1 in association with IRF5-mediated gene expression.
Subject(s)
Inflammation/pathology , Interferon Regulatory Factors/antagonists & inhibitors , Interferon Regulatory Factors/metabolism , Macrophages/metabolism , Nuclear Proteins/metabolism , Repressor Proteins/metabolism , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Cells, Cultured , Chromatin/genetics , Chromatin/metabolism , Co-Repressor Proteins/genetics , Co-Repressor Proteins/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Gene Silencing , HEK293 Cells , Histone Deacetylases/genetics , Histone Deacetylases/metabolism , Histone-Lysine N-Methyltransferase , Humans , Inflammation/genetics , Inflammation/metabolism , Interferon Regulatory Factors/genetics , Macrophages/pathology , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mice , Nuclear Proteins/genetics , Protein Interaction Domains and Motifs , Protein Methyltransferases/genetics , Protein Methyltransferases/metabolism , Repressor Proteins/genetics , Transcription, Genetic , Tripartite Motif-Containing Protein 28 , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolismSubject(s)
Lipopolysaccharides/pharmacology , Macrophages/metabolism , NF-kappa B/physiology , Transcription, Genetic/physiology , Tumor Necrosis Factor-alpha/genetics , Animals , Base Sequence , Cell Line, Transformed , Humans , Mice , Molecular Sequence Data , Oligodeoxyribonucleotides , Promoter Regions, Genetic , Transcription, Genetic/drug effectsSubject(s)
Antigens, CD/genetics , Autoimmune Diseases/genetics , Genetic Linkage , Genetic Markers , Polymorphism, Genetic , Receptors, Tumor Necrosis Factor/genetics , Base Sequence , Chromosome Mapping , DNA, Satellite , Humans , Molecular Sequence Data , Receptors, Tumor Necrosis Factor, Type IIABSTRACT
Transcriptional activation of the human TNF gene involves multiple regulatory elements whose functional properties vary between stimuli and cell types. Here we have used a COS-7 expression system to dissect the transactivating potential of NF-kappa B binding sites in the human TNF promoter region from other regulatory influences. In this model, NF-kappa B acts largely through a dense cluster of three binding sites located 600 nt upstream of the transcription start site. We show that the transcriptional activity of this complex is highly sensitive to the p65:p50 ratio that is expressed. We demonstrate that the AP-1 complex c-Jun/Fra2 is capable of binding to this region and that this inhibits the transactivating effects of NF-kappa B. These results are suggestive of a complex regulatory element that mediates fine control rather than acting as a simple on-off switch for TNF gene expression.
Subject(s)
NF-kappa B/metabolism , Promoter Regions, Genetic , Transcription Factor AP-1/metabolism , Tumor Necrosis Factor-alpha/genetics , Animals , Binding Sites/genetics , COS Cells , DNA-Binding Proteins/metabolism , Fos-Related Antigen-2 , Humans , NF-kappa B/chemistry , NF-kappa B p50 Subunit , Protein Subunits , Proto-Oncogene Proteins c-fos/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Sequence Deletion , Transcription Factor RelA , Transcription Factors/metabolism , Transcriptional ActivationABSTRACT
Variable major lipoprotein (Vmp) is a major tumor necrosis factor (TNF)-inducing component of Borrelia recurrentis, the agent of louse-borne relapsing fever. B. recurrentis Vmp rapidly stimulates nuclear translocation of NF-kappaB and proinflammatory cytokine gene expression in the human monocyte-like cell line MonoMac 6. By overexpressing disabled mutant IkappaBalpha in MonoMac 6 cells cotransfected with a reporter gene, we provide evidence that NF-kappaB is essential for the transcriptional activation of TNF in this system.
Subject(s)
Bacterial Proteins/physiology , Borrelia/physiology , NF-kappa B/physiology , Transcriptional Activation , Tumor Necrosis Factor-alpha/genetics , Cell Line , Cytokines/genetics , Humans , RNA, Messenger/analysisABSTRACT
TNF-alpha and lymphotoxin (LT, TNF-beta) genes are tandemly arranged and map within the MHC centromeric to HLA-B and telomeric to the class III genes. Both cytokines encoded by these genes are potent immunomodulators. On the other hand, some MHC-linked autoimmune diseases are characterized by abnormal levels of their expression or inducibility. A search for the putative disease-associated TNF/LT alleles depends on the informative genetic markers at the TNF locus. Previously, a low degree of genetic polymorphism at the human TNF locus has been reported, mostly bi-allelic RFLP. To localize and define additional polymorphic markers, we probed the collection of genomic clones with synthetic tandemly repeated dinucleotides, corresponding to the sequences known as microsatellites. We mapped and characterized three (TC/GA) and one (AC/GT) repeats within cloned 40-kb DNA comprising the human TNF locus. Using a polymerase chain reaction-based technique, we analyzed three of these four microsatellites and observed their length of polymorphism. Using DNA samples from blood donors, two families, and three human cell lines, we detected 13 distinct alleles of the AC/GT microsatellite neighboring human TNF genes. The variability was further increased by simultaneous analysis of the second linked microsatellite. This linked TC/GA repeat showed at least five alleles, whereas the least polymorphic TC/GA repeat located in the first intron of LT (TNF-beta) gene had two alleles. TNF alleles defined by microsatellites were stably inherited and segregated in the Mendelian way. Therefore, we describe thus far the most informative level of DNA sequence polymorphism in this part of human MHC. We propose a nomenclature for microsatellite tagged LT/TNF alleles based on their size and variability, which could also be extended to include RFLP and other not yet identified polymorphic markers. Microsatellite tagged polymorphism described here can be used in systematic linkage studies of HLA-associated diseases.
Subject(s)
Lymphotoxin-alpha/genetics , Polymorphism, Genetic , Tumor Necrosis Factor-alpha/genetics , Alleles , Base Sequence , Blotting, Southern , Chromosome Mapping , DNA, Satellite/genetics , Humans , Molecular Sequence Data , Oligonucleotide Probes , Pedigree , Polymerase Chain ReactionABSTRACT
We describe a dense cluster of DNA-protein interactions located 600 nucleotides upstream of the transcriptional start site of the human tumor necrosis factor (TNF) gene. This area was identified as being of potential importance for lipopolysaccharide-inducible TNF expression in the human monocyte cell line Mono Mac 6, based on reporter gene analysis of point mutations at a number of nuclear factor kappaB (NF-kappaB)-like motifs within the human TNF promoter region. The area contains two NF-kappaB sites, which are here shown by DNase I and methylation interference footprinting to flank a novel binding site. UV cross-linking studies reveal that the novel site can also bind NF-kappaB as well as an unknown protein(s) of approximately 40 kDa. We show that these three adjacent kappaB-binding sites differ markedly in their relative affinities for p50/p50, p65/p65, and p65/p50, yet this 39-nucleotide segment of DNA appears capable of binding up to three NF-kappaB heterodimers simultaneously. Reporter gene studies indicate that each element of the cluster contributes to lipopolysaccharide-induced transcriptional activation in Mono Mac 6 cells. These findings suggest that NF-kappaB acts in a complex manner to activate TNF transcription in human monocytes.
Subject(s)
Monocytes/metabolism , NF-kappa B/metabolism , Tumor Necrosis Factor-alpha/genetics , Base Sequence , Cell Line , DNA Footprinting , DNA Primers , Dimerization , Humans , NF-kappa B/genetics , Point Mutation , Protein Binding , Transcriptional ActivationABSTRACT
Oligonucleotide dendrimers were synthesized using a novel phosphoramidite synthon, tris-2,2,2-[3-(4,4'-dimethoxytrityloxy) propyloxymethyl]ethyl- N , N -diisopropylaminocyanethoxy phosphoramidite. Label, incorporated using [gamma-32P]ATP and polynucleotide kinase, was increased in proportion to the number of 5'-ends. There was a similar increase in signal when these multiply labelled oligonucleotides were used as probes to oligonucleotide arrays. A dendrimeric oligonucleotide was used successfully as a primer in the PCR. The strand bearing the dendrimer was resistant to degradation by T7 Gene 6 exonuclease making it easy to convert the double-stranded product of the PCR to a multiply-labelled, single-stranded probe.
Subject(s)
DNA Primers/chemical synthesis , DNA Probes/chemical synthesis , Oligonucleotides/chemical synthesis , Adenosine Triphosphate , Biopolymers , Isotope Labeling , Phosphorus Radioisotopes , Polymerase Chain Reaction , Polynucleotide 5'-Hydroxyl-KinaseABSTRACT
We have identified three polymorphic microsatellites (which we call TNFa, TNFb, and TNFc) within a 12-kilobase region of the human major histocompatibility complex (MHC) that includes the tumor necrosis factor (TNF) locus. TNFc is located within the first intron of the TNF-beta gene and has only 2 alleles. TNFa and TNFb are 3.5 kilobases upstream (telomeric) of the TNF-beta gene and have at least 13 and 7 alleles, respectively. TNFa, -b, and -c alleles are in linkage disequilibrium with alleles at other loci within the MHC, including class I, class II, and class III. TNFa, -b, and -c alleles are also associated with extended HLA haplotypes. These TNF polymorphisms will allow a thorough genetic analysis of the involvement of TNF in MHC-linked pathologies.
Subject(s)
HLA Antigens/genetics , Major Histocompatibility Complex , Polymorphism, Genetic , Tumor Necrosis Factor-alpha/genetics , Base Sequence , Gene Frequency , Genetic Linkage , Haplotypes , Humans , Molecular Sequence Data , Oligonucleotides/chemistry , Repetitive Sequences, Nucleic AcidABSTRACT
The human tumor necrosis factor locus (TNF locus) is located within the major histocompatibility complex between the class III genes and HLA-B. We recently characterized and studied two closely linked highly informative dinucleotide repeats (AC/GT)n (designated TNFa) and (TC/GA)k (designated TNFb) in the upstream region of the human TNF-beta (lymphotoxin) gene. We also characterized two linked (TC/GA) and (TC/GA)-like repeats located downstream of the TNF-alpha gene, designated TNFe and TNFd, respectively. Here, we combine these four markers together with a biallelic TC/GA repeat in the first intron of the TNF-beta gene (TNFc) and a biallelic NcoI RFLP (TNFn) to type 105 cell lines from the American Society of Histocompatibility and Immunogenetics Workshop and the Center for Human Polymorphism Studies reference panels of HLA typing cell lines. These 6 polymorphic markers define 35 distinct TNF haplotypes and together with the reference panel can be used for disease association and population genetics studies.
Subject(s)
Histocompatibility Testing/methods , Tumor Necrosis Factor-alpha/genetics , Alleles , B-Lymphocytes/immunology , Base Sequence , Cell Line , DNA/genetics , Genetic Markers , HLA Antigens/genetics , Haplotypes/genetics , Humans , Molecular Sequence Data , Polymerase Chain Reaction , Polymorphism, GeneticABSTRACT
Transcription of the TNF gene is rapidly and transiently induced by LPS in cells of monocyte/macrophage lineage. Previous data suggested that multiple NF-kappaB/Rel binding sites play a role in the transcriptional response to LPS of the murine gene. However, the relevance of homologous sites in the human TNF gene remained a matter of controversy, partly because the high affinity NF-kappaB/Rel site located at -510 in the murine promoter is not conserved in humans. Here we used two sets of similarly designed human and mouse TNF promoter deletion constructs and overexpression of IkappaB in the murine macrophage cell line ANA-1 to show remarkable similarity in the pattern of the transcriptional response to LPS, further demonstrating the functional role of the distal promoter region located between -600 and -650. This region was characterized by mutagenesis of protein binding sites, including two relatively low affinity NF-kappaB/Rel sites, #2 and 2a. Mutation in each of the NF-kappaB sites resulted in 2- to 3-fold lower transcriptional activity in response to LPS. In contrast to LPS activation, the response to PMA was substantially lower in magnitude and required only the proximal promoter region. In summary, the functional topography of human and murine promoters when assayed in the same system has some marked similarities. Our observations support the notion that full LPS response of TNF gene requires both NF-kappaB and non-NF-kappaB nuclear proteins. Our data also suggest that the functional activity of a given kappaB site depends on the entire DNA sequence context in the promoter region.
Subject(s)
Gene Expression Regulation/immunology , Lipopolysaccharides/immunology , Promoter Regions, Genetic/immunology , Tumor Necrosis Factor-alpha/genetics , Animals , Binding Sites/genetics , Binding Sites/immunology , Cell Line , DNA Mutational Analysis , Gene Expression Regulation/drug effects , Humans , Macrophages/immunology , Macrophages/metabolism , Mice , NF-kappa B/physiology , Protein Binding/genetics , Protein Binding/immunology , Sequence Homology, Nucleic Acid , Transcriptional Activation/immunologyABSTRACT
Interleukin-8 (IL-8) has been implicated in the pathogenesis of RSV-induced bronchiolitis. Previously, we have described an association between bronchiolitis disease severity and a specific IL-8 haplotype comprising six single-nucleotide polymorphisms (SNPs) (-251A/+396G/+781T/+1238delA/+1633T/+2767T, haplotype 2). Here we investigated the functional basis for this association by measuring haplotype-specific transcription in vivo in human primary cells. We found a significant increase in transcript level derived from the IL-8 haplotype 2 relative to the mirror haplotype 1 (-251T/+396T/+781C/+1238insA/+1633C/+2767A) in respiratory epithelial cells but not in lymphocytes. A promoter polymorphism, -251A, present on the high producer haplotype, had no significant affect on the allele-specific level of transcription when analyzed in reporter gene experiments in human respiratory epithelial A549 cells. We proceeded to systematically screen for allele-specific protein-DNA binding in this functional haplotype, which revealed significant differential binding at the +781T/C polymorphism. C/EBP beta was identified as being part of a transcription factor binding complex that preferentially bound in the presence of the +781 T allele. These results suggest that the mechanism for disease susceptibility to RSV-induced bronchiolitis may occur through a haplotype-specific increase in IL-8 transcription, which may be mediated by functional polymorphisms within that haplotype.